Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Combating Related Epidemics in HCV

NCT: NCT07560046 · NOT_YET_RECRUITING

NCT IDNCT07560046
StatusNOT_YET_RECRUITING
Start Date2026-08-01
Completion2030-12-30

Brief Summary

This is a two-arm cluster randomized control trial to evaluate the effectiveness of a single-visit point-of-care (POC) test and treat bundle (intervention arm) compared to the current standard-of-care (SOC, control arm). 1:1 randomization occurs at the site level.

Frequently Asked Questions

What is Combating Related Epidemics in HCV?

Combating Related Epidemics in HCV is a clinical trial registered under NCT07560046. Current status: NOT_YET_RECRUITING.

What is the status of NCT07560046?

The current status of NCT07560046 (Combating Related Epidemics in HCV) is: NOT_YET_RECRUITING.

When did Combating Related Epidemics in HCV start?

Combating Related Epidemics in HCV started on 2026-08-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑